Gut microbiome as a modulator of inflammation in chronic heart failure
Kazan medical journal · 28.05.2026 · 107 (4) · 615-625
DOI: 10.17816/kmj701308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 28.05.2026. Verfasst von Elena V. Khazova und 4 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
In recent years, the amount of scientific data indicating the key role of the gut microbiome in modulating immune responses that influence myocardial remodeling and the progression of chronic heart failure has been growing. Modulating the composition and function of the gut microbiome to reduce the severity of lowgrade inflammation and slow the progression of chronic heart failure appears to be an innovative approach. This review aimed to analyze the role of the gut microbiome in cytokine-dependent inflammation in heart failure. Fifty-two sources containing data on associations between cytokine levels and gut microbiome bacterial genera in patients with heart failure, published from 1999 to 2025 in journals indexed in PubMed and eLibrary.ru, were analyzed. The review includes a description of modern molecular methods for studying the gut microbiome, along with their advantages and disadvantages. Changes in the taxonomic and quantitative composition of the gut microbiome and in the cytokine profile of patients with heart failure are presented. The data presented in the analyzed publications demonstrate a link between specific bacterial taxa and cytokine levels in certain phenotypic groups of chronic heart failure; however, the mechanisms underlying these relationships often remain the subject of further research. The identified limitations in the design of the reviewed studies, such as the presence of comorbidities, medication use, and unadjusted analyses that do not always account for confounding variables (diet and physical activity), underscore the need for further research to confirm these associations. Promising directions include research into diseasemodifying treatment for chronic heart failure, including the development of methods to modulate the microbiota in order to reduce cytokinemediated myocardial damage.
Zitieren
APA
Khazova, E. V., Khairullin, A. E., Tyurin, Y. A., Kurmaeva, N. S., & Suleymanova, А. I. (2026). Gut microbiome as a modulator of inflammation in chronic heart failure. Kazan medical journal, 107(4), 615-625. https://doi.org/10.17816/kmj701308
Vancouver
Khazova EV, Khairullin AE, Tyurin YA, Kurmaeva NS, Suleymanova АI. Gut microbiome as a modulator of inflammation in chronic heart failure. Kazan medical journal. 2026;107(4):615-625. doi:10.17816/kmj701308
BibTeX
@article{Khazova2026,
author = {Khazova, Elena V. and Khairullin, Adel E. and Tyurin, Yuri A. and Kurmaeva, Naira Sh. and Suleymanova, Аlbina I.},
title = {Gut microbiome as a modulator of inflammation in chronic heart failure},
journal = {Kazan medical journal},
year = {2026},
volume = {107},
number = {4},
pages = {615--625},
doi = {10.17816/kmj701308}
}
EUVIMED